Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Risako Higa

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Clinical Ophthalmology

Ophthalmology

2012

English

Investigation of the Difference of the Predicted Refraction Between SRK/T and Haigis Fomulas

JAPANESE ORTHOPTIC JOURNAL

2016

English

Related publications

Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

European Ophthalmic Review

2009

English

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost

Open Ophthalmology Journal

Ophthalmology

2016

English

Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients

Clinical Ophthalmology

Ophthalmology

2010

English

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Journal of Ophthalmology

Ophthalmology

2018

English

Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study

English

Intraocular Pressure Reduction Using a Fixed Combination of Timolol Maleate 0.5% and Brimonidine Tartrate 0.2% Administered Three Times Daily

Clinical Ophthalmology

Ophthalmology

2013

English

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

Clinical Ophthalmology

Ophthalmology

2011

English

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

English

Managing Refractory Glaucoma With a Fixed Combination of Bimatoprost (0.03%) and Timolol (0.5%)

Clinical Ophthalmology

Ophthalmology

2008

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Risako Higa

Efficacy and Safety of a Switch to Latanoprost 0.005% + Timolol Maleate 0.5% Fixed Combination Eyedrops From Latanoprost 0.005% Monotherapy

Investigation of the Difference of the Predicted Refraction Between SRK/T and Haigis Fomulas

Related publications

Treatment of Glaucoma With the Fixed Combination of Latanoprost 0.005% and Timolol 0.5%

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost

Efficacy, Safety, and Tolerability of Travoprost 0.004% BAK-free Versus Prior Treatment With Latanoprost 0.005% in Japanese Patients

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy

Polyquad-Preserved Travoprost/Timolol, Benzalkonium Chloride (BAK)-preserved Travoprost/Timolol, and Latanoprost/Timolol in Fixed Combinations: A Rabbit Ocular Surface Study

Intraocular Pressure Reduction Using a Fixed Combination of Timolol Maleate 0.5% and Brimonidine Tartrate 0.2% Administered Three Times Daily

Addition of a Fixed Combination of Brinzolamide 1%/Timolol 0.5% to Prostaglandin Monotherapy in Patients With Glaucoma or Ocular Hypertension

24-Hour Efficacy and Ocular Surface Health With Preservative-Free Tafluprost Alone and in Conjunction With Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled With Preserved Latanoprost Monotherapy

Managing Refractory Glaucoma With a Fixed Combination of Bimatoprost (0.03%) and Timolol (0.5%)